James Noble, MD, MS, Associate Professor of Neurology in the Taub Institute and the Sergievsky Center at CUMC discusses his diverse body of work and the motivation behind his passion projects.
Lawrence S. Honig, MD, PhD, Professor of Neurology at CUMC, comments on the suggestion that some people may have developed Alzheimer's disease after receiving growth hormones
Caghan Kizil, PhD, MSc, Associate Professor of Neurological Sciences in Neurology and in the Taub Institute, talks about using zebrafish as a model organism in his research.
Miguel Arce Rentería, PhD, Assistant Professor of Neuropsychology (in Neurology), speaks about factors that may contribute to an increased risk of developing dementia or Alzheimer's disease in Latinos
Caghan Kizil, PhD, MSc, Associate Professor of Neurological Sciences (in Neurology & in the Taub Institute) and colleagues discovered a mechanism that promotes neurogenesis in the zebrafish brain
Carol M. Troy, MD, PhD, Professor of Pathology & Cell Biology and Neurology at CUMC, discusses, based on a new study, how eye drops could be more effective in treating retinal vein occlusion
Dr. Lawrence S. Honig, Professor of Neurology at the CUIMC, comments on the significance of Food and Drug Administration approval of the Alzheimer’s disease drug, Lecanemab
Lawrence S. Honig, MD, PhD, Professor of Neurology at the CUIMC, an investigator for the study that led to the FDA’s approval of Leqembi expresses his opinions about the new Alzheimer’s Disease drug
Jennifer J. Manly, PhD, Professor of Neuropsychology, and Lawrence S. Honig, MD, PhD, Professor of Neurology, comment on donanemab, the second Alzheimer’s drug
Lawrence S. Honig, MD, PhD, a professor of neurology at CUIMC, estimates that group constitutes about a sixth of the more than 6 million Americans currently diagnosed with Alzheimer’s
Stephanie Cosentino, PhD, Associate Professor of Neuropsychology, and colleagues are working on developing screening tools to detect subjective cognitive decline and more advanced forms of memory loss
A new study done by Dr. Jennifer Manly, professor of neuropsychology, and colleagues, found that the quality of the high school you attend may have an impact on cognition later in life
Richard Mayeux, MD, chair of the Department of Neurology at CUMC and colleagues are investigating a set of blood tests that may help correctly diagnose Alzheimer disease in low-resource environments